- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED May 08, 2024
Companies with a Value score of at least 3, ordered by Value score
446 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PCRX | US$29.65 | 10.0% | -30.9% | US$1.2b | US$45.55 | PE19.6x | E25.6% | n/a | ||
AMPH | US$42.21 | 0.3% | 2.5% | US$2.1b | US$62.60 | PE15x | E19.0% | n/a | ||
KNSA | US$20.26 | 4.4% | 43.0% | US$1.4b | US$30.67 | PE166.2x | E44.1% | n/a | ||
EXAS | US$59.48 | -0.9% | -24.5% | US$11.3b | US$89.48 | PS4.4x | E61.9% | n/a | ||
SPPI | US$1.03 | 5.3% | 17.0% | US$209.9m | US$1.26 | PS8.2x | E67.3% | n/a | ||
OCUP | US$1.83 | 11.6% | -70.7% | US$49.7m | US$19.50 | PS2.5x | E9.5% | n/a | ||
AKYA | US$4.11 | 3.8% | -37.5% | US$201.5m | US$9.00 | PS2.1x | E55.3% | n/a | ||
SUPN | US$31.30 | 4.1% | -14.8% | US$1.7b | US$40.33 | PE1307.5x | E58.3% | n/a | ||
BIO | US$268.26 | -2.1% | -26.6% | US$8.0b | US$412.50 | PS2.9x | E38.1% | n/a | ||
INDV | UK£17.78 | 0.9% | -7.9% | UK£1.9b | UK£30.24 | PE485.3x | E34.7% | 0% | ||
SCYX | US$1.84 | 7.0% | -36.3% | US$69.7m | US$6.88 | PE1x | E0.04% | n/a | ||
JUSH.F | US$0.69 | -3.6% | 27.5% | US$129.8m | US$1.08 | PE-2.1x | S6.1% | n/a | ||
FOLD | US$10.14 | -2.8% | -12.4% | US$3.1b | US$18.78 | PS7.5x | E55.6% | n/a | ||
GILD | US$64.92 | -0.9% | -16.9% | US$81.6b | US$82.93 | PE166.9x | E36.5% | 4.7% | ||
PRGO | US$31.11 | -5.4% | -14.7% | US$4.1b | US$39.50 | PE5269.9x | E49.3% | 3.5% | ||
MDXG | US$7.20 | -1.5% | 18.8% | US$1.1b | US$12.68 | PE15.5x | E13.2% | n/a | ||
CYRX | US$13.20 | -21.5% | -38.8% | US$806.3m | US$18.00 | PS2.9x | E32.0% | n/a | ||
SNCE | US$5.75 | 0.3% | 30.9% | US$34.7m | US$13.83 | PB0.7x | E66.7% | n/a | ||
BAYZ.F | €30.28 | 3.3% | -52.9% | €28.0b | €39.24 | PB0.8x | E46.3% | 0.4% | ||
RPRX | US$27.99 | -0.3% | -17.3% | US$16.9b | US$45.88 | PE11.1x | E6.3% | 3.0% | ||
HITI | CA$2.40 | 9.6% | 79.1% | CA$237.2m | CA$4.38 | PB1.9x | E134.8% | n/a | ||
OGN | US$20.37 | 8.2% | -5.3% | US$5.2b | US$22.50 | PE5x | E4.1% | 5.5% | ||
RCEL | US$8.96 | 3.6% | -44.1% | US$241.7m | US$25.90 | PS4.6x | E62.0% | n/a | ||
GTHX | US$4.29 | 3.9% | 46.9% | US$222.2m | US$8.50 | PS2.7x | E48.2% | n/a |